Footnote: SD censored individual continues to be in follow-up with steady disease 1
Footnote: SD censored individual continues to be in follow-up with steady disease 1.6?years after begin of treatment Baseline median CT doubling period and CEA doubling period showed a variety rendering it difficult to interpret because of small patient amount. type 2a (SSTR2a) appearance from the tumor by immunohistochemistry. Retrospective evaluation of traditional 111In-DTPA-octreotide scans of…